Abstract:
Two homeopathic drug provings (HDPs) of RNA have been published. The methods are
reviewed. Our method is double-blind and placebo-controlled, conforms to GCP and
includes run-in and follow-up phases. Symptoms are selected from diaries according to
predefined criteria. The results of the provings are compared with each other and with
the homeopathic clinical use of RNA. At this stage it is difficult to draw conclusions
concerning the clinical use of RNA. Further HDPs are required, they should follow GCP
and standard, transparent protocols.